PR Newswire Clinical TrialsOriginal article
Galmed Announces Successful First-in-Human Proof-of-Concept Clinical Study Results for Colospan's Novel Intraoperative Tissue Assessment Technology
Phase 1positiveColospanPositive
AI Analysis
Summary
Galmed announced positive first-in-human proof-of-concept results for Colospan's intraoperative tissue assessment technology in a 32-patient colorectal cancer study, establishing clinical feasibility for quantitative colon tissue quality measurement.
Clinical Trial Data
Phase
Phase 1
Primary Endpoint
Met
Patients
32
Outcome Details
First-in-human proof-of-concept study demonstrated feasibility of intraoperative quantitative measurement of colon tissue quality
Importance:6/10
Sentiment:
0.70
clinical_trialfirst-in-humanproof-of-conceptcolorectal_cancerintraoperative_assessment
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on August 19, 2026 11:00 AM